MICROBA LIFE SCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.18 AUD | +12.50% |
|
-2.70% | 0.00% |
| Apr. 23 | Microba's Revenue Climbs 297% in Fiscal Q3 | MT |
| Apr. 10 | Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5% | MT |
Evolution of the average Target Price on Microba Life Sciences Limited
Price target over the last 5 years
History of analyst recommendation changes
9df4b6609e4603ff803afc052752.mwtsU-ziGPIZtmAgY8Xl7dzOERhKNfnv-yC2swbSLvM.zm9bFLSzcItc4Qp3IKOdm5OmQVkuXpaeyVXyg2CxbIKtOSEYs4tColHbAw~748c932517ac9b645dc831ac1a29c9a9
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.18
AUD
Average target price
0.38
AUD
Spread / Average Target
+111.11%
High Price Target
0.44
AUD
Spread / Highest target
+144.44%
Low Price Target
0.35
AUD
Spread / Lowest Target
+94.44%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MAP Stock
- Consensus Microba Life Sciences Limited
